Kremer JM - Search Results

1

Kremer JM, Reed G, Pappas DA, Kane K, Feathers VL, Weinblatt ME, Shadick N, Greenberg J, Harrold LL. Kremer JM, et al. J Rheumatol. 2022 Mar;49(3):338-339. doi: 10.3899/jrheum.210992. Epub 2021 Oct 15. J Rheumatol. 2022. PMID: 34654733 No abstract available.

2

Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.

Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G, Henson B, Rubin P, Sperling R. Weinblatt ME, et al. Among authors: kremer jm. J Rheumatol. 1992 Oct;19(10):1537-41. J Rheumatol. 1992. PMID: 1334515 Clinical Trial.

3

Methotrexate 1989--the evolving story.

Kremer JM. Kremer JM. J Rheumatol. 1989 Mar;16(3):261-3. J Rheumatol. 1989. PMID: 2724244 No abstract available.

4

Methotrexate in rheumatoid arthritis.

Weinblatt ME, Kremer JM. Weinblatt ME, et al. Among authors: kremer jm. J Am Acad Dermatol. 1988 Jul;19(1 Pt 1):126-8. doi: 10.1016/s0190-9622(88)80220-2. J Am Acad Dermatol. 1988. PMID: 3042815 Review. No abstract available.

5

Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.

Kremer JM, Petrillo GF, Hamilton RA. Kremer JM, et al. J Rheumatol. 1995 Jan;22(1):38-40. J Rheumatol. 1995. PMID: 7699678 Clinical Trial.

6

Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.

Kremer JM, Petrillo GF, Hamilton RA. Kremer JM, et al. J Rheumatol. 1995 Jan;22(1):41-4. J Rheumatol. 1995. PMID: 7699679 Clinical Trial.

7

The effects of food on methotrexate absorption.

Hamilton RA, Kremer JM. Hamilton RA, et al. Among authors: kremer jm. J Rheumatol. 1995 Apr;22(4):630-2. J Rheumatol. 1995. PMID: 7791153

8

Lack of a renal-protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin A. Results of a randomized, placebo-controlled trial.

Weinblatt ME, Germain BF, Kremer JM, Wall BA, Weisman MH, Maier AL, Coblyn JS. Weinblatt ME, et al. Among authors: kremer jm. Arthritis Rheum. 1994 Sep;37(9):1321-5. doi: 10.1002/art.1780370908. Arthritis Rheum. 1994. PMID: 7945495 Clinical Trial.

9

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.

Kremer JM, Alarcón GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME. Kremer JM, et al. Arthritis Rheum. 1994 Mar;37(3):316-28. doi: 10.1002/art.1780370304. Arthritis Rheum. 1994. PMID: 8129787

10

Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis.

Walker AM, Funch D, Dreyer NA, Tolman KG, Kremer JM, Alarcón GS, Lee RG, Weinblatt ME. Walker AM, et al. Among authors: kremer jm. Arthritis Rheum. 1993 Mar;36(3):329-35. doi: 10.1002/art.1780360307. Arthritis Rheum. 1993. PMID: 8452577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page